Table 1 Baseline patient characteristics (demographics and disease characteristics).
Variables | Ferric Carboxymaltose group |
|---|---|
Age (years), median, IQRa | 66 ± 16 |
Gender, n (%) | |
Male | 49 (49.5) |
Female | 50 (50.5) |
Cancer type, n (%) | |
Colorectal | 22 (22.2) |
Gastric | 22 (22.2) |
Breast | 21 (21.2) |
Pancreas | 11 (11.1) |
Gynaecological | 7 (7.1) |
Lung | 4 (4.1) |
Othersb | 12 (12.1) |
Disease stage at diagnosis, n (%) | |
I-III | 60 (60.6) |
IV | 39 (39.4) |
Intention treatment at inclusion, n (%) | |
Curative | 45 (45.5) |
Palliative | 54 (54.5) |
Ongoing chemotherapy at inclusion, n (%) | 94 (94.9%) |
Iron Deficiency, n (%) | |
Absolute | 18 (18.2) |
Relative | 81 (81.8) |
